Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001448788-21-000006
Filing Date
2021-03-15
Accepted
2021-03-15 16:05:42
Documents
95
Period of Report
2021-01-31

Document Format Files

Seq Description Document Type Size
1 SUNWIN STEVIA INTERNATIONAL, INC. FORM 10-Q suwn10-q.htm 10-Q 1039060
2 SECTION 302 CERTIFICATE OF CHIEF EXECUTIVE OFFICER exh31-1.htm EX-31.1 7693
3 SECTION 302 CERTIFICATE OF CHIEF FINANCIAL OFFICER exh31-2.htm EX-31.2 7723
4 SECTION 906 CERTIFICATE OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER exh32-2.htm EX-32.1 5320
  Complete submission text file 0001448788-21-000006.txt   3682485

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT suwn-20210131.xml EX-101.INS 500402
6 XBRL TAXONOMY EXTENSION SCHEMA suwn-20210131.xsd EX-101.SCH 107229
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE suwn-20210131_cal.xml EX-101.CAL 23129
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE suwn-20210131_def.xml EX-101.DEF 36991
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE suwn-20210131_lab.xml EX-101.LAB 253497
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE suwn-20210131_pre.xml EX-101.PRE 194981
Mailing Address 6 SHENGWANG AVENUE, QUFU, SHANDONG F4 273100
Business Address 6 SHENGWANG AVENUE, QUFU, SHANDONG F4 273100 (86) 537-4424999
SUNWIN STEVIA INTERNATIONAL, INC. (Filer) CIK: 0000806592 (see all company filings)

EIN.: 562416925 | Fiscal Year End: 0430
Type: 10-Q | Act: 34 | File No.: 000-53595 | Film No.: 21741519
SIC: 2834 Pharmaceutical Preparations